Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shangzhao Li

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature Communications|September 26, 2025
Fe-electrocatalytic deoxygenative Giese reactionLonghui Yu, Shangzhao Li, Hiroshige Ogawa, et al.
Chemical Science|June 12, 2026
Reprogramming RiPP scaffolds through skeletal editing unlocks chemical spaceHiroshige Ogawa, Longhui Yu, Shangzhao Li, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2024
Concise Synthesis of Cyctetryptomycin A and B Enabled by Zr-Catalyzed DimerizationLonghui Yu, Hiroshige Ogawa, Shangzhao Li, et al.
Frontiers in Medicine|March 13, 2025
Efficacy of Kegan Liyan oral liquid vs. Lianhuaqingwen capsules for patients with mild COVID-19: a double-blinded, randomized, controlled, non-inferiority trialYuewei Li, Yihe Chi, Mengting Zhu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Communications|September 26, 2025
Fe-electrocatalytic deoxygenative Giese reactionLonghui Yu, Shangzhao Li, Hiroshige Ogawa, et al.
Chemical Science|June 12, 2026
Reprogramming RiPP scaffolds through skeletal editing unlocks chemical spaceHiroshige Ogawa, Longhui Yu, Shangzhao Li, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2024
Concise Synthesis of Cyctetryptomycin A and B Enabled by Zr-Catalyzed DimerizationLonghui Yu, Hiroshige Ogawa, Shangzhao Li, et al.
Frontiers in Medicine|March 13, 2025
Efficacy of Kegan Liyan oral liquid vs. Lianhuaqingwen capsules for patients with mild COVID-19: a double-blinded, randomized, controlled, non-inferiority trialYuewei Li, Yihe Chi, Mengting Zhu, et al.
Pageof 1